Understanding the Radiobiological Mechanisms Induced by
177Lu-DOTATATE
DNA damage
PARP inhibition
external beam radiation therapy
radiobiology
radionuclide therapy
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
15 Oct 2022
15 Oct 2022
Historique:
received:
22
08
2022
revised:
07
10
2022
accepted:
12
10
2022
entrez:
27
10
2022
pubmed:
28
10
2022
medline:
29
10
2022
Statut:
epublish
Résumé
Radionuclide Therapy (RNT) with
Identifiants
pubmed: 36293222
pii: ijms232012369
doi: 10.3390/ijms232012369
pmc: PMC9604190
pii:
doi:
Substances chimiques
Receptors, Somatostatin
0
Ribose
681HV46001
Octreotide
RWM8CCW8GP
Organometallic Compounds
0
Radiopharmaceuticals
0
Radioisotopes
0
Adenosine Diphosphate
61D2G4IYVH
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Association Jules Bordet
ID : 2016-15
Références
Radiat Res. 2015 Apr;183(4):455-64
pubmed: 25807320
Phys Med. 2018 Dec;56:41-49
pubmed: 30527088
Nucl Med Biol. 2018 May;60:11-18
pubmed: 29502008
Lancet Oncol. 2020 Sep;21(9):e431-e443
pubmed: 32888472
Nucl Med Biol. 2021 May-Jun;96-97:68-79
pubmed: 33839677
J Nucl Med. 2021 Dec;62(Suppl 3):12S-22S
pubmed: 34857617
Cell. 2018 Aug 9;174(4):843-855.e19
pubmed: 30017245
Oxid Med Cell Longev. 2019 Mar 12;2019:1279250
pubmed: 30992736
Radiother Oncol. 2004 Dec;73(3):373-82
pubmed: 15588885
NAR Cancer. 2021 Dec 22;3(4):zcab046
pubmed: 35692378
Mol Cancer Ther. 2011 Oct;10(10):1949-58
pubmed: 21825006
EJNMMI Phys. 2020 Feb 10;7(1):8
pubmed: 32040783
Cancer Treat Rev. 2010 Nov;36(7):566-75
pubmed: 20409643
Front Med (Lausanne). 2015 Mar 17;2:12
pubmed: 25853132
Cancer Lett. 2012 Dec 31;327(1-2):48-60
pubmed: 22182453
Curr Oncol. 2020 Dec 21;28(1):115-127
pubmed: 33622997
Br J Dermatol. 2000 Feb;142(2):210-22
pubmed: 10730751
Nucl Med Biol. 2022 Jan-Feb;104-105:53-64
pubmed: 34922279
Clin Cancer Res. 2017 Aug 15;23(16):4617-4624
pubmed: 28428192
Sci Rep. 2020 Jun 23;10(1):10196
pubmed: 32576907
Eur J Nucl Med Mol Imaging. 2021 Oct;48(11):3365-3377
pubmed: 33912987
Radiat Res. 2021 Jan 1;195(1):47-59
pubmed: 33181852
J Neuroendocrinol. 2022 Apr;34(4):e13109
pubmed: 35304807
Front Cell Dev Biol. 2020 Sep 09;8:564601
pubmed: 33015058
Biomedicines. 2021 Oct 29;9(11):
pubmed: 34829796
EJNMMI Phys. 2018 Sep 3;5(1):18
pubmed: 30175390
Cell Death Dis. 2022 May 28;13(5):505
pubmed: 35643812
Int J Oncol. 2012 Jan;40(1):176-84
pubmed: 21879255
Radiother Oncol. 2015 Sep;116(3):358-65
pubmed: 25981132
N Engl J Med. 2017 Jan 12;376(2):125-135
pubmed: 28076709
Int J Mol Sci. 2022 Jul 21;23(14):
pubmed: 35887398
J Radiat Res. 2006 Nov;47(3-4):245-57
pubmed: 16960336
Theranostics. 2016 Jul 18;6(11):1821-32
pubmed: 27570553
Nat Med. 2012 Aug;18(8):1239-47
pubmed: 22820643
J Cell Mol Med. 2019 Apr;23(4):2303-2313
pubmed: 30672100
Br J Radiol. 2017 Jan;90(1069):20160474
pubmed: 27416998
Nat Rev Clin Oncol. 2013 Jan;10(1):52-60
pubmed: 23183635
Eur J Nucl Med Mol Imaging. 2019 Jul;46(8):1588-1590
pubmed: 31069454
J Nucl Med. 2020 May;61(5):743-750
pubmed: 31757844